Table 1.

Timeline and overview of assessments after providing written informed consent

	Baseline			Follow-up (6 months)*			Follow-up (12 months)*			Follow-up (24 months)*
	First 24–48 hours	Within 7 days	Within 14 days	First 24–48 hours	Within 7 days	Within 14 days	First 24–48 hours	Within 7 days	Within 14 days	First 24–48 hours	Within 7 days	Within 14 days
Standard routine assessments
Blood withdrawal to assess hormonal and metabolic profiles	X			X			X			X
Clinical Assessment	X			X			X			X
Neurocognitive screening (CANTAB, 40–50 min)	X			X			X			X
Actigraphy setup for circadian profiling (duration of the profiling: 6–14 days)	X			X			X			X
Feedback session (CANTAB, clinical assessments)		X			X			X			X
Feedback session (Actigraphy)			X			X			X			X
Additional asssessments
Self report questionnaire (45–60 min)		X			X			X			X

A feedback session is offered routinely and will be organised after completion of the assessments.

*We are in the process of an ethics amendment to include an additional 6 months and 12 months follow-up to improve the care provided. Clinical assessment is only done in participants that are readmitted to Uspace within the follow-up period.

CANTAB, Cambridge Neuropsychological Test Automated Battery.